Joy Ann Carlos
Family · Paramount, CANPI 1548014921
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 8.7% — the pattern of someone who eats at a lot of different presentations.
Across 77 payments — averaging $27.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$183
- Daiichi Sankyo Inc.$177
- Johnson & Johnson$160
- Puma Biotechnology, Inc.$118
- AstraZeneca$118
- Seagen Inc.$99
- plus $1K from 33 others
What the payments were for
- Food & beverage$1,93792%
- Education$1778%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 6 | $183 |
| Daiichi Sankyo Inc. | 7 | $177 |
| Johnson & Johnson | 6 | $160 |
| Puma Biotechnology, Inc. | 5 | $118 |
| AstraZeneca(2 entities) | 4 | $118 |
| Seagen Inc. | 1 | $99 |
| Genentech USA, Inc. | 3 | $81 |
| Lilly USA, LLC | 3 | $78 |
| Genmab U.S., Inc. | 2 | $66 |
| Pfizer | 3 | $62 |
| Iovance Biotherapeutics, Inc. | 2 | $61 |
| Incyte Corporation | 2 | $59 |
| AVEO Pharmaceuticals, Inc. | 2 | $55 |
| Sanofi | 2 | $54 |
| Gilead | 2 | $52 |
| Stemline Therapeutics Inc. | 2 | $47 |
| Eisai Inc. | 2 | $46 |
| Apellis Pharmaceuticals, Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Caris MPI, Inc. | 1 | $34 |
| Geron Corporation | 1 | $33 |
| Bayer | 1 | $32 |
| Karyopharm Therapeutics Inc. | 1 | $31 |
| Shield Therapeutics Inc | 1 | $30 |
| Cycle Pharmaceuticals Inc | 1 | $30 |
| Tempus AI, Inc | 1 | $30 |
| EMD Serono, Inc. | 1 | $29 |
| GSK | 1 | $29 |
| Progenics Pharmaceuticals, Inc. | 1 | $27 |
| Sobi, Inc | 1 | $26 |
| Blueprint Medicines Corporation | 1 | $26 |
| Legend Biotech USA Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Cipher Pharmaceuticals US LLC | 1 | $21 |
| AbbVie | 1 | $21 |
| Adaptive Biotechnologies Corporation | 1 | $19 |
| Chiesi USA, Inc. | 1 | $18 |
| Rigel Pharmaceuticals, Inc. | 1 | $17 |
| Servier Pharmaceuticals LLC | 1 | $16 |
How this compares
$2,114 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Other family in Paramount
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.